27(top 2%)
papers
544(top 2%)
citations
14(top 2%)
h-index
24(top 2%)
g-index
28
all documents
591
doc citations
192
citing journals

Top Articles

#TitleJournalYearCitations
1Gold Standards in PharmacovigilanceDrug Safety200777
2Safety Related Drug-Labelling ChangesDrug Safety200452
3An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System DatabaseDrug Safety201050
4Data Mining in PharmacovigilanceDrug Safety200547
5Drug-induced pancreatitis: lessons in data miningBritish Journal of Clinical Pharmacology200445
6Early Postmarketing Drug Safety Surveillance: Data Mining Points to ConsiderAnnals of Pharmacotherapy200437
7Potential Use of Data-Mining Algorithms for the Detection of ???Surprise??? Adverse Drug ReactionsDrug Safety200734
8Communication of findings in pharmacovigilance: use of the term “signal” and the need for precision in its useEuropean Journal of Clinical Pharmacology200531
9Illusions of objectivity and a recommendation for reporting data mining resultsEuropean Journal of Clinical Pharmacology200725
10Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance toolsInternational Journal of Infectious Diseases200722
11What Counts in Data Mining?Drug Safety200619
12Data mining in pharmacovigilance: lessons from phantom shipsEuropean Journal of Clinical Pharmacology200619
13Reports of hyperkalemia after publication of RALES—a pharmacovigilance studyPharmacoepidemiology and Drug Safety200616
14Response to letter by Levine et al.British Journal of Clinical Pharmacology200616
15Detection of Spironolactone-Associated Hyperkalaemia Following the Randomized Aldactone Evaluation Study (RALES)Drug Safety200715
16Endotoxin-Like Reactions With Intravenous Gentamicin Results From Pharmacovigilance Tools Under InvestigationInfection Control and Hospital Epidemiology200511
17Signal Detection in the Pharmaceutical IndustryDrug Safety200711
18Antidepressants that inhibit neuronal norepinephrine reuptake are not associated with increased spontaneous reporting of cardiomyopathyJournal of Psychopharmacology201011
19Paradoxical Reactions: Under-Recognized Adverse Effects of Drugs?Drug Safety20068
20The Importance of Reporting Negative Findings in Data MiningPharmaceutical Medicine20088
21Data mining, drug safety, and molecular pharmacology: potential for collaborationAnnals of Pharmacotherapy20046
22A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigationBritish Journal of Clinical Pharmacology20046
23Rosiglitazone-induced immune thrombocytopeniaPlatelets20066
24Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysisEuropean Journal of Gastroenterology and Hepatology20075
25Data Mining in PharmacovigilancePharmaceutical Medicine20075
26Reports of Acute Angle Closure Glaucoma-Related Adverse Events with SSRIs: Results of a Disproportionality AnalysisCNS Drugs20064
27Extension of Points on Clarifying Terminology in Drug SafetyDrug Safety20064
28Number Needed to DetectPharmaceutical Medicine20081